You searched for "GMC"
The GMC joins the mobile revolution
If you are an ophthalmologist practising in the UK the increasing need to log your educational activities for your Annual Review of Competence Progression (ARCP) or appraisal can’t possibly have escaped you. The existing tools in this area for ophthalmologists...NHS leaders must support doctors to act on new GMC guidance to challenge concerning behaviour at work
Dr John Holden responds to the publication of the revised Good Medical Practice (GMP) guidance from the General Medical Council.
Incidence of ocular myasthenia gravis and risk factors for conversion to generalised disease
This population based retrospective cohort study evaluates the incidence of ocular myasthenia gravis (OMG) as well as risk factors for transformation to generalised myasthenia gravis (GMG). Sixty-five patients (40 male and 25 female) with newly diagnosed with myasthenia gravis (MG)...A Nightmare on Doctor Street
“Number one: you can never have sex. Big no no! Big no no! Sex equals death, okay?Number two: you can never drink or do drugs. The sin factor! It’s a sin. It’s an extension of number one.And number three: never,...
Retinal changes in Leber hereditary optic neuropathy
The objective of this study was to describe the changes in the retinal ganglion cell complex (GCC) relative to the retinal nerve fibre layer (RNFL) over time, in patients with Leber’s hereditary optic neuropathy (LHON). For this study, 21 patients...
Comparison of ganglion cell thinning in glaucoma vs. macular hole repair
This prospective study compared the changes in the photopic negative response of the focal macular electroretinogram (fmERG) caused by retinal ganglion cell complex (GCC) thinning at the macula between patients with open angle glaucoma (OAG) and 12 months after successful...
Assaying acetylcholine receptor antibodies in the diagnosis of ocular myasthenia
Myasthenia gravis (MG) is an autoimmune disease that leads to impaired neuromuscular transmission. Solely ocular manifestations of MG (OMG) occur in 15-50% of cases, most frequently in the form of fluctuating ptosis and diplopia. Most cases of OMG convert later...AOP update on new GOC e-service for statutory notices
The GOC intends to introduce email communication for statutory notices with consent.Designing ophthalmology services Part 2: How do we address the queues for a clinic?
The first of this three-part series showed how systems engineering can be used to correctly diagnose and address the causes of delays in a clinic. This second article describes how to design a more productive system that meets the new...
Adjunctive topical 5-FU vs. MMC for surgically excised, localised OSSN
Ocular surface squamous neoplasia (OSSN) comprises a range of dysplasia including corneal-conjunctival intraepithelial neoplasia and invasive squamous cell carcinoma. The traditional treatment for localised non-invasive OSSN has been surgical excision with or without intraoperative cryotherapy. Postoperative adjunctive topical chemotherapy significantly...
